Norges Bank’s Day One Biopharmaceuticals DAWN Stock Holding History

Norges Bank’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-169,000	Closed	-$1.58M	–	380
2025 Q4	$1.58M	Buy	+169,000	New	+$1.41M	﹤0.01%	1467
2025 Q3	–	Sell	-169,000	Closed	-$1.1M	–	425
2025 Q2	$1.1M	Hold	169,000	–	–	﹤0.01%	1527
2025 Q1	$1.34M	Hold	169,000	–	–	﹤0.01%	1584
2024 Q4	$2.14M	Hold	169,000	–	–	﹤0.01%	1683
2024 Q3	$2.35M	Hold	169,000	–	–	﹤0.01%	1643
2024 Q2	$2.33M	Hold	169,000	–	–	﹤0.01%	1696
2024 Q1	$2.79M	Hold	169,000	–	–	﹤0.01%	1706
2023 Q4	$2.47M	Hold	169,000	–	–	﹤0.01%	1777
2023 Q3	$2.07M	Hold	169,000	–	–	﹤0.01%	1821
2023 Q2	$2.02M	Hold	169,000	–	–	﹤0.01%	1869
2023 Q1	$2.26M	Buy	169,000 +61,000	+56%	+$1.19M	﹤0.01%	1908
2022 Q4	$2.32M	Buy	+108,000	New	+$2.22M	﹤0.01%	1947

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Norges Bank's DAWN Position: Q1 2026 in Review

Norges Bank sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 169,000 shares — an estimated $1.58M sold.

Norges Bank first reported a position in DAWN in Q4 2022 and held it in 12 quarters. The position peaked at $2.79M in Q1 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

Norges Bank reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 169,000 Day One Biopharmaceuticals shares in Q1 2026, an estimated $1.58M.
Norges Bank first reported a position in Day One Biopharmaceuticals in Q4 2022 and held it in 12 quarters.
Norges Bank's Day One Biopharmaceuticals position peaked at $2.79M in Q1 2024.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.